Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Sharing good diabetes practice in the NHS

Breaking down healthcare silos to demonstrate the benefits and adaptability of diabetes care initiatives

- PMLiVE

Global medicines spend to reach $1.3trn by 2018

IMS report suggests end of the ‘patent cliff’

Sanofi reception

Sanofi plans 18 new product launches by 2020

Keen to reinstall faith of investors after firing CEO Viehbacher

- PMLiVE

US proposes tighter rules on clinical trial reporting

If approved, data from around 650 additional studies per year will be released

- PMLiVE

EU approval for Gilead’s hep C combo Harvoni

Another boost for the company’s fast-growing Sovaldi franchise

- PMLiVE

Johan Heylen leaves GSK for Ablynx

He joins Nanobody specialist as chief commercial officer

- PMLiVE

AZ seeks leg up in antiplatelet market with Brilinta antidote

Reversal agent has been developed by company's biotech subsidiary Medimmune

- PMLiVE

Merck Serono brings electronic MS device to six more countries

RebiSmart works alongside the company's MSdialog web-based software

- PMLiVE

MSF disputes Tufts’ estimates on cost of drug development

Center for the Study of Drug Development says it takes up to $2.5bn to bring a drug to market

- PMLiVE

NICE wants more info on Novartis’ Xolair in chronic hives

Says company must provide more data on the drug's effectiveness

- PMLiVE

PCSK9 inhibitor alirocumab works in statin-intolerance

Sanofi and Regeneron’s drug impresses at American Heart Association meeting

Jacques Dumas joins Nosopharm scientific advisory board

French biotech's appointments also include Dominique Breilh

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links